Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission

New England Journal of Medicine

Volumn 341, Issue 7, 1999, Pages 476-484

  Aupérin, Anne ^a   Arriagada, Rodrigo ^a,b   Pignon, Jean Pierre ^a   Le Péchoux, Cécile ^a   Gregor, Anna ^c   Stephens, Richard J ^d   Kristjansen, Paul E G ^e   Johnson, Bruce E ^f   Ueoka, Hiroshi ^g   Wagner, Henry ^h   Aisner, Joseph ⁱ  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b Instituto de Radiomedicina Santiago   (Chile)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

^d MEDICAL RESEARCH COUNCIL   (United Kingdom)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f WALTER REED ARMY MEDICAL CENTER   (United States)

^g OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^h H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

ⁱ RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN METASTASIS; BRAIN RADIATION; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; META ANALYSIS; PRIORITY JOURNAL; RADIATION DOSE; REMISSION; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CARCINOMA, SMALL CELL; CRANIAL IRRADIATION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; REMISSION INDUCTION; RISK; SURVIVAL ANALYSIS;

EID: 0345062339     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199908123410703     Document Type: Article

References (39)

1. Albain KS, Crowley JJ, LeBlanc M, Livingston RB. Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base. J Clin Oncol 1990;8:1563-74.
2. Arriagada R, Kramar A, Le Chevalier T, De Cremoux H. Competing events determining relapse-free survival in limited small-cell lung carcinoma. J Clin Oncol 1992;10:447-51.
3. Turrisi AT III, Kim K, Blum R, et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concur-rently with cisplatin and etoposide. N Engl J Med 1999;340:265-71.
4. Komaki R. Prophylactic cranial irradiation for small cell carcinoma of the lung. Cancer Treat Symp 1985;2:35-9.
5. Arriagada R, Le Chevalier T, Boric F, et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst 1995;87:183-90.
6. Hirsch FR, Paulson OB, Hansen HH, Vraa-Jensen J. Intracranial metastases in small cell carcinoma of the lung: correlation of clinical and autopsy findings. Cancer 1982;50:2433-7.
7. Hansen HH. Should initial treatment of small cell carcinoma include systemic chemotherapy and brain irradiation? Cancer Chemother Rep 1973;4:239-41.
8. Kristjansen PEG, Kristensen CA. The role of prophylactic cranial irradiation in the management of small cell lung cancer. Cancer Treat Rev 1993;19:3-16.
9. Rosen ST, Makuch RW, Lichter AS, et al. Role of prophylactic cranial irradiation in prevention of central nervous system metastases in small cell lung cancer: potential benefit restricted to patients with complete response. Am J Med 1983;74:615-24.
10. Catane R, Schwade JG, Yarr I, et al. Follow-up and neurological evaluation in patients with small cell lung carcinoma treated with prophylactic cranial irradiation and chemotherapy. Int J Radiat Oncol Biol Phys 1981; 7:105-9.
11. Johnson BE, Patronas N, Hayes W, et al. Neurologic, computed cranial tomographic, and magnetic resonance imaging abnormalities in patients with small-cell lung cancer: further follow-up of 6-to 13-year survivors. J Clin Oncol 1990;8:48-56.
12. Lee JS, Umsawasdi T, Lee YY, et al. Neurotoxicity in long-term survivors of small cell lung cancer. Int J Radiat Oncol Biol Phys 1986;12:313-21.
13. Lishner M, Feld R, Payne DG, et al. Late neurological complications after prophylactic cranial irradiation in patients with small-cell lung cancer: the Toronto experience. J Clin Oncol 1990;8:215-21.
14. Frytak S, Shaw JN, O'Neill BP, et al. Leukoencephalopathy in small cell lung cancer patients receiving prophylactic cranial irradiation. Am J Clin Oncol 1989;12:27-33.
15. Gregor A, Cull A, Stephens RJ, et al. Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trial. Eur J Cancer 1997; 33:1752-8.
16. Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials 1996;17:343-6.
17. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Treatment of early breast cancer. Vol. 1. Worldwide evidence 1985-1990: a systematic overview of all available randomized trials of adjuvant endocrine and cytotoxic therapy. Oxford, England: Oxford University Press, 1990.
18. Stewart LA, Parmar MKB. Meta-analysis of the literature or of individual patient data: is there a difference? Lancet 1993;341:418-22.
19. Jackson DV Jr, Richards F II, Cooper MR, et al. Prophylactic cranial irradiation in small cell carcinoma of the lung: a randomized study. JAMA 1977;237:2730-3.
20. Cox JD, Petrovich Z, Paig C, Stanley K. Prophylactic cranial irradiation in patients with inoperable carcinoma of the lung: preliminary report of a cooperative trial. Cancer 1978;42:1135-40.
21. Beiler DD, Kane RC, Bernath AM, Cashdollar MR. Low dose elective brain irradiation in small cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 1979;5:941-5.
22. Hansen HH, Dombernowsky P, Hirsch FR, Hansen M, Rygard J. Prophylactic irradiation in bronchogenic small cell anaplastic carcinoma: a comparative trial of localized versus extensive radiotherapy including prophylactic brain irradiation in patients receiving combination chemotherapy. Cancer 1980;46:279-84.
23. Maurer LH, Tulloh M, Weiss RB, et al. A randomized combined modality trial in small cell carcinoma of the lung: comparison of combination chemotherapy-radiation therapy versus cyclophosphamide-radiation therapy effects of maintenance chemotherapy and prophylactic whole brain irradiation. Cancer 1980;45:30-9.
24. Eagan RT, Frytak S, Lee RE, Crcagan ET, Ingle JN, Nichols WC. A case for preplanned thoracic and prophylactic whole brain radiation therapy in limited small-cell lung cancer. Cancer Clin Trials 1981;4:261-6.
25. Katsenis AT, Karpasitis N, Giannakakis D, Maragoudakis N, Kiparissiadis P. Elective brain irradiation in patients with small-cell carcinoma of the lung: preliminary report. In: Pontifex G, ed. Lung cancer: etiology, epidemiology, prevention, early diagnosis, treatment. Amsterdam: Excerpta Medica, 1982:277-84.
26. Mountain CF, Vincent R, Wilson HE, Stanley K. Intensive chemotherapy and radiotherapy of small cell carcinoma of the lung-regional disease. In: Abstracts of the Third World Conference on Lung Cancer, Tokyo, Japan, May 17-20, 1982:153. abstract.
27. Seydel HG, Creech R, Pagano M, et al. Prophylactic versus no brain irradiation in regional small cell lung carcinoma. Am J Clin Oncol 1985;8: 218-23.
28. Niiranen A, Holsti P, Salmo M. Treatment of small cell lung cancer: two-drug versus four-drug chemotherapy and loco-regional irradiation with or without prophylactic cranial irradiation. Acta Oncol 1989;28:501-5.
29. Aroney RS, Aisner J, Wesley MN, et al. Value of prophylactic cranial irradiation given at complete remission in small cell lung carcinoma. Cancer Treat Rep 1983;67:675-82.
30. Ohonoshi T, Ueoka H, Kawahara S, et al. Comparative study of prophylactic cranial irradiation in patients with small cell lung cancer achieving a complete response: a long-term follow-up result. Lung Cancer 1993;10: 47-54.
31. Laplanche A, Monnet I, Santos-Miranda JA, et al. Controlled clinical trial of prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Lung Cancer 1998;21:193-201.
32. Wagner H, Kim K, Turrisi A. A randomized phase III study of prophylactic cranial irradiation versus observation in patients with small cell lung cancer achieving a complete response: final report of an incomplete trial by the Eastern Cooperative Oncology Group and Radiation Therapy Oncology Group (E3589/R92-01). Proc Am Soc Clin Oncol 1996;15:376. abstract.
33. Ahles TA, Silberfarb PM, Herndon J II, et al. Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: a study by the Cancer and Leukemia Group B. J Clin Oncol 1998;16: 1954-60.
34. Arriagada R, Pignon JP, Ihde DC, et al. Effect of thoracic radiotherapy on mortality in limited small cell lung cancer: a meta-analysis of 13 randomized trials among 2,140 patients. Anticancer Res 1994;14:333-5.
35. Murray N, Coy P, Pater JL, et al. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. J Clin Oncol 1993;11:336-44.
36. Johnson BE, Bridges JD, Sobczeck M, et al. Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine. J Clin Oncol 1996;14:806-13.
37. Rosenman J, Choi NC. Improved quality of life of patients with small-cell carcinoma of the lung by elective irradiation of the brain. Int J Radiat Oncol Biol Phys 1982;8:1041-3.
38. Suwinski R, Lee SP, Withers HR. Dose-response relationship for prophylactic cranial irradiation in small cell lung cancer. Int J Radiat Oncol Biol Phys 1998;40:797-806.
39. Perez CA, Krauss S, Bartolucci AA, et al. Thoracic and elective brain irradiation with concomitant or delayed multiagent chemotherapy in the treatment of localized small cell carcinoma of the lung: a randomized prospective study by the Southeastern Cancer Study Group. Cancer 1981;47: 2407-13.